A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial
Titel:
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial
Auteur:
Chang-Monteagudo, Arturo Ochoa-Azze, Rolando Climent-Ruiz, Yanet Macías-Abraham, Consuelo Rodríguez-Noda, Laura Valenzuela-Silva, Carmen Sánchez-Ramírez, Belinda Perez-Nicado, Rocmira Hernández-García, Tays Orosa-Vázquez, Ivette Díaz-Hernández, Marianniz García-García, María de los Ángeles Jerez-Barceló, Yanet Triana-Marrero, Yenisey Ruiz-Villegas, Laura Rodríguez-Prieto, Luis Dairon Puga-Gómez, Rinaldo Guerra-Chaviano, Pedro Pablo Zúñiga-Rosales, Yaíma Marcheco-Teruel, Beatriz Rodríguez-Acosta, Mireida Noa-Romero, Enrique Enríquez-Puertas, Juliet Porto-González, Delia Fernández-Medina, Olivia Valdés-Zayas, Anet Chen, Guang-Wu Herrera-Martínez, Luís Valdés-Balbín, Yury García-Rivera, Dagmar Verez-Bencomo, Vicente